GlaxoSmithKline makes bold move with £130m Covid-19 investment | Nils Pratley

  • 📰 The Guardian
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 53%

Brasil Notícia Notícia

Brasil Últimas Notícias,Brasil Manchetes

GSK’s share price has been left standing by AstraZeneca’s high-risk success in cancer treatments

Monday’s most important vaccine news was the promising early data from the Oxford University and AstraZeneca coronavirus trial – “robust immune responses” is encouraging. But let’s not overlook other vaccine developments. The industry has been viewed for years as a dull subsector of the pharmaceutical business; now it is a whir of deal-making activity.

 

Obrigado pelo seu comentário. Seu comentário será publicado após ser revisado.

Bold? With Lord Backsheesh Of Durham At Barnham Castle?

Fuck your poison dart. We know the shite that is in it. The people are waking up!

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

 /  🏆 84. in BR

Brasil Últimas Notícias, Brasil Manchetes